Posted: August 15, 2016 at 11:46 am
Stem cells: What they are and what they do Stem cells and derived products offer great promise for new medical treatments. Learn about stem cell types, current and possible uses, ethical issues, and the state of research and practice. By Mayo Clinic Staff
You’ve heard about stem cells in the news, and perhaps you’ve wondered if they might help you or a loved one with a serious disease. You may wonder what stem cells are, how they’re being used to treat disease and injury, and why they’re the subject of such vigorous debate.
Here are some answers to frequently asked questions about stem cells.
Researchers and doctors hope stem cell studies can help to:
Generate healthy cells to replace diseased cells (regenerative medicine). Stem cells can be guided into becoming specific cells that can be used to regenerate and repair diseased or damaged tissues in people.
People who might benefit from stem cell therapies include those with spinal cord injuries, type 1 diabetes, Parkinson’s disease, Alzheimer’s disease, heart disease, stroke, burns, cancer and osteoarthritis.
Stem cells may have the potential to be grown to become new tissue for use in transplant and regenerative medicine. Researchers continue to advance the knowledge on stem cells and their applications in transplant and regenerative medicine.
Test new drugs for safety and effectiveness. Before using new drugs in people, some types of stem cells are useful to test the safety and quality of investigational drugs. This type of testing will most likely first have a direct impact on drug development for cardiac toxicity testing.
New areas of study include the effectiveness of using human stem cells that have been programmed into tissue-specific cells to test new drugs. For testing of new drugs to be accurate, the cells must be programmed to acquire properties of the type of cells to be tested. Techniques to program cells into specific cells continue to be studied.
For instance, nerve cells could be generated to test a new drug for a nerve disease. Tests could show whether the new drug had any effect on the cells and whether the cells were harmed.
Stem cells are the body’s raw materials cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells.
These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle or bone. No other cell in the body has the natural ability to generate new cell types.
Researchers have discovered several sources of stem cells:
Embryonic stem cells. These stem cells come from embryos that are three to five days old. At this stage, an embryo is called a blastocyst and has about 150 cells.
These are pluripotent (ploo-RIP-uh-tunt) stem cells, meaning they can divide into more stem cells or can become any type of cell in the body. This versatility allows embryonic stem cells to be used to regenerate or repair diseased tissue and organs, although their use in people has been to date limited to eye-related disorders such as macular degeneration.
Adult stem cells. These stem cells are found in small numbers in most adult tissues, such as bone marrow or fat. Compared with embryonic stem cells, adult stem cells have a more limited ability to give rise to various cells of the body.
Until recently, researchers thought adult stem cells could create only similar types of cells. For instance, researchers thought that stem cells residing in the bone marrow could give rise only to blood cells.
However, emerging evidence suggests that adult stem cells may be able to create unrelated types of cells. For instance, bone marrow stem cells may be able to create bone or heart muscle cells. This research has led to early-stage clinical trials to test usefulness and safety in people. For example, adult stem cells are currently being tested in people with neurological or heart disease.
This new technique may allow researchers to use these reprogrammed cells instead of embryonic stem cells and prevent immune system rejection of the new stem cells. However, scientists don’t yet know if altering adult cells will cause adverse effects in humans.
Researchers have been able to take regular connective tissue cells and reprogram them to become functional heart cells. In studies, animals with heart failure that were injected with new heart cells experienced improved heart function and survival time.
Perinatal stem cells. Researchers have discovered stem cells in amniotic fluid in addition to umbilical cord blood stem cells. These stem cells also have the ability to change into specialized cells.
Amniotic fluid fills the sac that surrounds and protects a developing fetus in the uterus. Researchers have identified stem cells in samples of amniotic fluid drawn from pregnant women during a procedure called amniocentesis, a test conducted to test for abnormalities.
More study of amniotic fluid stem cells is needed to understand their potential.
Embryonic stem cells are obtained from early-stage embryos a group of cells that forms when a woman’s egg is fertilized with a man’s sperm in an in vitro fertilization clinic. Because human embryonic stem cells are extracted from human embryos, several questions and issues have been raised about the ethics of embryonic stem cell research.
The National Institutes of Health created guidelines for human stem cell research in 2009. Guidelines included defining embryonic stem cells and how they may be used in research and donation guidelines for embryonic stem cells. Also, guidelines stated embryonic stem cells may only be used from embryos created by in vitro fertilization when the embryo is no longer needed.
The embryos being used in embryonic stem cell research come from eggs that were fertilized at in vitro fertilization clinics but never implanted in a woman’s uterus. The stem cells are donated with informed consent from donors. The stem cells can live and grow in special solutions in test tubes or petri dishes in laboratories.
Although research into adult stem cells is promising, adult stem cells may not be as versatile and durable as are embryonic stem cells. Adult stem cells may not be able to be manipulated to produce all cell types, which limits how adult stem cells can be used to treat diseases.
Adult stem cells also are more likely to contain abnormalities due to environmental hazards, such as toxins, or from errors acquired by the cells during replication. However, researchers have found that adult stem cells are more adaptable than was initially suspected.
See more here:
Stem cells: What they are and what they do – Mayo Clinic
- Human heart muscle made from stem cells - Free Press Journal - March 26th, 2017
- Measuring Heart Toxicity of Cancer Drugs | Technology Networks - Technology Networks - March 24th, 2017
- Pathologists and Clinical Laboratories May Soon Have a Test for Identifying Cardiac Patients at Risk from Specific ... - DARKDaily.com - Laboratory... - March 23rd, 2017
- 'Beating' Heart Created from Stem Cells - Technology Networks - March 22nd, 2017
- Stem Cell Cardiac Toxicity Model for Testing Chemotherapy Agents - Technology Networks - March 21st, 2017
- Self-repairing heart tissue breakthrough brings hope for cardiac patients - ABC Online - March 16th, 2017
- Scientists create 'beating' human heart muscle for cardiac research - UQ News - March 16th, 2017
- Belgium's Tigenix says heart attack stem cell trial successful - Reuters - March 15th, 2017
- Cardiac researcher Milica Radisic to present keynote address at Libin Institute's Cardiac Research Day - UCalgary News - March 15th, 2017
- Daiichi Sankyo forges $12M pact for GPCR pain program with Heptares; Incyte shares jump on latest takeover chatter - Endpoints News - March 14th, 2017
- Woodrose Ventures Corporation Announces Proposed Acquisition ... - Marketwired (press release) - March 14th, 2017
- TiGenix Announces Top-Line Phase I/II Results of AlloCSC-01 in Acute Myocardial Infarction - GlobeNewswire (press release) - March 14th, 2017
- Belgium's Tigenix says heart attack stem cell trial successful - KFGO - March 13th, 2017
- TiGenix Announces Top-Line Phase I/II Results of AlloCSC-01 in Acute Myocardial Infarction - P&T Community - March 13th, 2017
- VistaGen Therapeutics Inc. (Nasdaq: VTGN) to Ring The Nasdaq ... - GlobeNewswire (press release) - March 10th, 2017
- Cardiac research nets Holly Mewhort prestigious heart association award - UCalgary News - March 10th, 2017
- TiGenix Announces Positive Topline Week-104 Data for Cx601 ADMIRE-CD Trial - P&T Community - March 10th, 2017
- Robert Clayton Robbins Top Choice for UA President - Arizona Public Media - March 9th, 2017
- Mountain News: Clinic advances stem-cell research - Pique Newsmagazine - March 9th, 2017
- Stem Cell Therapy receives FDA Boost to enter the US Market - Labiotech.eu (blog) - March 8th, 2017
- Using Stem Cells to Predict Toxicity of Chemotherapy Drugs ... - ScienceBlog.com (blog) - March 6th, 2017
- Student profile: Keegan Mendez - Harvard School of Engineering and Applied Sciences - March 6th, 2017
- Opinion/Commentary: Global stem cell therapy market to showcase ... - The Daily Progress - March 5th, 2017
- Stem cell therapy can help in treating diabetic heart disease - Business Standard - March 4th, 2017
- Stem cell therapy can help treat diabetic heart disease - Economic Times - March 1st, 2017
- Johns Hopkins Medicine, Maryland Stem Cell Research Fund and ... - Business Wire (press release) - March 1st, 2017
- StemBioSys Lands Experimental UT Tech That Finds Young Stem Cells - Xconomy - March 1st, 2017
- TiGenix to present at Cowen's 37th Annual Health Care Conference in Boston - EconoTimes - March 1st, 2017
- Stem cell therapy can help in treating diabetic heart disease - India.com - February 28th, 2017
- Canadian Pacific makes a $1 million gift to fund stem cell research at the CHU Sainte-Justine - New hope for ... - Canada NewsWire (press release) - February 28th, 2017
- Heart failure BREAKTHROUGH: Stem cells trial offers hope to millions - Express.co.uk - February 25th, 2017
- Cardiac injury, recovery is topic of Osher lecture - Stowe Today - February 24th, 2017
- Nanostraw doesn't destroy cells as it samples their guts - Futurity - Futurity: Research News - February 24th, 2017
- Less Acute MI, More HF: European Task Force Shifts Support for 'Overhyped' Cell Therapy Research - TCTMD - February 22nd, 2017
- Nanostraws Sample Cells Without Damage - R & D Magazine - February 22nd, 2017
- CardioBrief: After Yet Another Failure, Stem Cell Leaders Double Down - MedPage Today - February 21st, 2017
- Minuscule nanostraws sample a cell's contents without damage ... - Stanford University News - February 21st, 2017
- Researchers implicate suspect in heart disease linked to diabetes - Medical Xpress - February 21st, 2017
- Cardiac Muscle Cells Create Living Diode - Controlled Environments Magazine - February 16th, 2017
- Scientists create scorecard index for heart-damaging chemo drugs - Medical Xpress - February 16th, 2017
- Researchers develop 'living diode' using cardiac muscle cells - Science Daily - February 15th, 2017
- VistaGen Therapeutics Reports Fiscal Third Quarter 2017 Financial ... - Yahoo Finance - February 13th, 2017
- Stem Cell Basics VI. | stemcells.nih.gov - February 10th, 2017
- Myocardial Stem Cell Patch Developed with 3D Printer - BusinessKorea - February 10th, 2017
- Function of olfactory receptor in the human heart identified - Medical Xpress - February 8th, 2017
- Regrowing heart muscles without cancer risk, using synthetic stem cells - Genetic Literacy Project - February 7th, 2017
- World Stem Cell Summit - December 23rd, 2016
- Induced stem cells - Wikipedia - November 29th, 2016
- Cardiac muscle - Wikipedia - November 27th, 2016
- Cardiac muscle cell - Wikipedia - November 23rd, 2016
- 2016 Market Research Reports on 5000+ Sectors at ... - November 11th, 2016
- Cardiac stem cells: biology and clinical applications. - November 7th, 2016
- Home | EMBO Reports - October 15th, 2016
- Muscle - Wikipedia, the free encyclopedia - September 23rd, 2016
- Regenerative Medicine Conferences | Tissue Engineering ... - September 22nd, 2016
- How Your Heart Works | HowStuffWorks - September 22nd, 2016
- Cardiology Conferences | Events | Meetings | Florida | USA ... - September 8th, 2016
- Stripping donor hearts and repopulating them with ... - August 13th, 2016
- Induction of Pluripotent Stem Cells from Adult Human ... - August 13th, 2016
- Heart - Wikipedia, the free encyclopedia - August 2nd, 2016
- Stem cell trial suggests damaged heart tissue could be ... - July 28th, 2016
- Where Do We Get Adult Stem Cells? | Boston Children's Hospital - July 24th, 2016
- Stem Cell Assays Reproducible Research on Stem Cells - July 24th, 2016
- Stem-cell therapy - Wikipedia, the free encyclopedia - July 21st, 2016
- Autologous mesenchymal stem cells produce concordant ... - July 18th, 2016
- Bone marrow mesenchymal stem cells stimulate cardiac stem ... - June 16th, 2016
- Isoproterenol directs hair follicle-associated pluripotent ... - May 19th, 2016
- Stem cell therapy for heart failure: first implant of ... - May 7th, 2016
- Cardiac muscle cells as good as progenitors for heart ... - April 20th, 2016
- Resident c-kit+ cells in the heart are not cardiac stem ... - April 19th, 2016
- Isolation and Expansion of Adult Cardiac Stem Cells From ... - April 2nd, 2016
- Human cardiac stem cells - PNAS - March 22nd, 2016
- Growing beating cardiac tissue from stem cells: New model ... - March 10th, 2016
- Development of a scalable suspension culture for cardiac ... - March 4th, 2016
- Adult Cardiac Stem Cells Are Multipotent and Support ... - February 27th, 2016
- Stem Cells News -- ScienceDaily - February 12th, 2016
- Cardiac muscle cell - Wikipedia, the free encyclopedia - February 1st, 2016
- Regenocyte, Stem Cells Used To Treat Cardiovascular Disease - January 28th, 2016
- Challenges in identifying the best source of stem cells ... - October 25th, 2015
- Endogenous cardiac stem cell - Wikipedia, the free ... - October 24th, 2015